Test Code |
Test Name |
Location |
Methodology |
Disease Category |
MRP |
Days |
MGM1048
|
Maple syrup urine disease, type II (DBT) gene analysis |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM1054
|
MECP2 gene sequencing |
Bangalore |
Next Generation Sequencing |
Neurology |
14000 |
21 |
MGM1135
|
TPMT and NUDT15 gene analysis |
Bangalore |
Next Generation Sequencing |
Oncology |
14000 |
14 |
MGM1177
|
Mucopolysaccharidosis type VI (ARSB) gene sequencing |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM1180
|
Chylomicron retention disease (SAR1B) gene sequencing |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM1215
|
Leukocyte adhesion deficiency (ITGB2) gene sequencing |
Bangalore |
Next Generation Sequencing |
Immunology |
14000 |
21 |
MGM1310
|
IGF1 gene sequencing |
Bangalore |
Next Generation Sequencing |
Rare inherited diseases |
14000 |
21 |
MGM1319
|
Ornithine transcarbamylase deficiency (OTC) gene sequencing |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM1330
|
WT1 gene sequencing - germline mutations |
Bangalore |
Next Generation Sequencing |
Rare inherited diseases |
14000 |
21 |
MGM1354
|
CYP3A5 testing for Tacrolimus dosing |
Bangalore |
Next Generation Sequencing |
Immunology |
14000 |
14 |
MGM1457
|
IDUA gene analysis (Mucopolysaccharidosis Ih) |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM340
|
DPYD mutation analysis |
Bangalore |
Next Generation Sequencing |
Oncology |
14000 |
14 |
MGM360
|
Gilbert syndrome (UGT1A1) gene analysis (only point mutation analysis) |
Bangalore |
Next Generation Sequencing |
Gastroenterology |
14000 |
21 |
MGM385
|
GM1 gangliosidosis/mucopolysaccharidosis type IVB (GLB1) gene analysis |
Bangalore |
Next Generation Sequencing |
Metabolic Disorders |
14000 |
21 |
MGM443
|
Methemoglobinemia (CYB5R3) gene analysis |
Bangalore |
Next Generation Sequencing |
Hematology |
14000 |
21 |
|
|